Trial Profile
A pilot study of central venous catheter survival in cancer patients using low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis [DVT] of the upper extremity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2022
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 11 Dec 2005 New trial record.